Oncoinvent ASA Financial Flexibility Index
Oncoinvent ASA financial flexibility index. Oncoinvent ASA (ONCIN) has a Financial Flexibility Index of -3.74x as of June 2025. Free cash flow of Nkr-73.90 Million (operating CF Nkr-73.90 Million minus capex Nkr0.00) represents -4% of total liabilities (Nkr19.75 Million). Check asset resilience ratio of Oncoinvent ASA to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Oncoinvent ASA (2021–2025)
Financial flexibility index of Oncoinvent ASA from 2021 to 2025. Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. Explore ONCIN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Oncoinvent ASA Financial Flexibility Index by Year (2021–2025)
Oncoinvent ASA financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Oncoinvent ASA. For the full cash flow conversion analysis, see cash flow conversion of Oncoinvent ASA.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.24x | Nkr-131.07 Million | Nkr-131.19 Million | Nkr58.63 Million | ▲ +7.5% |
| 2024 | -2.42x | Nkr-151.44 Million | Nkr-153.24 Million | Nkr62.68 Million | ▼ -1.7% |
| 2023 | -2.37x | Nkr-111.29 Million | Nkr-138.11 Million | Nkr46.86 Million | ▲ +34.7% |
| 2022 | -3.63x | Nkr-284.25 Million | Nkr-288.23 Million | Nkr78.21 Million | ▲ +21.2% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr-303.34 Million | Nkr65.81 Million | — |